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Abstract
With the recent success of genome-wide association studies (GWAS), a wealth of association data has been accomplished
for more than 200 complex diseases/traits, proposing a strong demand for data integration and interpretation. A
combinatory analysis of multiple GWAS datasets, or an integrative analysis of GWAS data and other high-throughput data,
has been particularly promising. In this study, we proposed an integrative analysis framework of multiple GWAS datasets by
overlaying association signals onto the protein-protein interaction network, and demonstrated it using schizophrenia
datasets. Building on a dense module search algorithm, we first searched for significantly enriched subnetworks for
schizophrenia in each single GWAS dataset and then implemented a discovery-evaluation strategy to identify module genes
with consistent association signals. We validated the module genes in an independent dataset, and also examined them
through meta-analysis of the related SNPs using multiple GWAS datasets. As a result, we identified 205 module genes with a
joint effect significantly associated with schizophrenia; these module genes included a number of well-studied candidate
genes such as DISC1, GNA12, GNA13, GNAI1, GPR17, and GRIN2B. Further functional analysis suggested these genes are
involved in neuronal related processes. Additionally, meta-analysis found that 18 SNPs in 9 module genes had
Pmeta,1610
24, including the gene HLA-DQA1 located in the MHC region on chromosome 6, which was reported in previous
studies using the largest cohort of schizophrenia patients to date. These results demonstrated our bi-directional network-
based strategy is efficient for identifying disease-associated genes with modest signals in GWAS datasets. This approach can
be applied to any other complex diseases/traits where multiple GWAS datasets are available.
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Introduction
Genome-wide association (GWA) studies have, during the past
decade, become a powerful tool to study the genetic components
of complex diseases [1]. Although an increasing number of genes/
markers have been uncovered in GWA studies, which have
provided us important insights into the underlying genetic basis of
complex diseases such as schizophrenia [2,3,4], it has also become
evident that many genes are weakly or moderately associated with
the diseases. Most of these variants have been missed in single
marker analysis, as investigators typically employ a genome-wide
significance cutoff P-value of 561028. Alternatively, the gene set
analysis (GSA) of GWAS datasets provides ways to simultaneously
examine groups of functionally related genes for their combined
effects and thus have improved power and interpretability [5].
Many GSA methods have been reported to date, such as the
gene set enrichment analysis [6], the adaptive rank-truncated
product [7], the gene set ridge regression in association studies
(GRASS) [8], etc. Most of these methods were designed to use pre-
defined gene sets such as the KEGG database [9] or the Gene
Ontology (GO) annotations [10]. Alternatively, studies are
emerging by incorporating protein-protein interaction (PPI)
networks into GWAS analysis. Baranzini et al. [11] first adopted
a network-based method that was initially designed for gene
expression data [12] to analyze the GWAS data for multiple
sclerosis. Recently, Rossin et al. [13] developed the Disease
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Association Protein-Protein Link Evaluator (DAPPLE); it tests
whether genes that are located at association loci in a GWAS
dataset are significantly connected via PPIs. We have also
developed the dense module search (DMS) method [14], which
overlays the gene-wise P values from GWAS onto the PPI network
and dynamically searches for subnetworks that are significantly
enriched with the association signals.
The advantages of network-based analysis of GWAS data in
comparison with the standard GSA methods lie in many aspects.
First, most GSA methods test on pre-defined gene sets, which
heavily rely on a priori knowledge and are incomplete. For
example, the popular KEGG database has pathway annotations
covering only ,5,000–5,500 genes [15], accounting for less than
30% of the genes in GWAS datasets. In contrast, the annotations
of PPI data cover a much larger proportion of human proteins.
For example, a recent integrative analysis of PPI data from
multiple sources has reconstructed the human PPI network by
recruiting,12,000 proteins and,60,000 protein interaction pairs
with experimental evidence [16]. There are other assembled PPI
datasets that include both experimentally supported and compu-
tationally predicted interactions; thus, they could annotate even
more proteins and interactions [17,18]. Second, the standard GSA
methods are typically based on canonical definitions of pathways
or functional categories, but the association signals from GWAS
might converge on only part of the pathway [19]. In such cases,
analysis of the whole pathway as a unit would reduce the power.
On the other hand, network-assisted methods allow for the
definition of de novo gene sets by dynamically searching for
interconnected subnetworks in the whole interactome and, thus,
can effectively alleviate the limitation of the fixed size in pathway
analysis.
Despite these advantages, there are challenges in the application
of network-based approaches to GWAS data. For example, the
methods for defining or searching subnetworks vary greatly. While
it is impractical to examine all possible subnetworks due to the
intensive computing burden, different methods or algorithms may
identify substantially different subnetworks [20], making it difficult
to decide in real application. Additionally, network-based analysis
could be confounded by nodes with high degrees (i.e., the number
of interactors of each node in the network), although these nodes
constitute only a small proportion according to the framework of
power-law distribution [21]. One example is TP53, which
interacts with several hundreds of other proteins in the whole
PPI network. The existence of such hub nodes with strong
interaction in the network may help them more likely to be
selected in searching subnetworks and, thus, overwhelm the
resultant subnetworks. Appropriate adjustments are needed.
In this study, we aim to search for modules that are significantly
enriched with association signals in human PPI network weighted
by GWAS signals. We take advantage of our recently developed
dense module search (DMS) algorithm [14] to conduct module
searching and construction. Based on this, we introduced statistical
evaluations of the modules identified by DMS, including a
significance test based on module scores, a weighted resampling
method to adjust potential biased in GWAS data (e.g., caused by
gene length or SNP density), a topologically matched randomi-
zation process to adjust the bias in network (e.g., the high degree
nodes), and a permutation test to determine the disease association
of the modules. In addition, we propose a bi-directional
framework to search for consistent association signals from
multiple GWAS datasets available for one specific disease or trait.
Specifically, two GWAS datasets were analyzed in parallel: one is
assigned as a discovery dataset and another as an evaluation
dataset, and vice versa. This strategy provides robust results with
partial validation — only the modules that were consistently highly
scored would be selected for further validation and functional
assessment. We demonstrated it in schizophrenia using two major
GWAS datasets for module identification, and incorporated a
third dataset to independently replicate the results. Finally, we
performed a meta-analysis of the markers that were mapped in the
module genes. We identified 18 SNPs in 9 module genes that are
of particular interests (Pmeta,1610
24).
Results
An overview of the network framework for GWAS
We incorporated two case-control GWAS datasets for schizo-
phrenia in this study for module search: the International
Schizophrenia Consortium (ISC) study and the Genetic Associa-
tion Information Network (GAIN) dataset. A third dataset, the
Molecular Genetics of Schizophrenia (MGS) - nonGAIN dataset,
was included in the validation stage by bringing independent
samples for disease association test. Each of the three datasets was
preprocessed and quality controlled, with none observed to have
substantial population stratification. As shown in Figure 1, we
started with the GAIN dataset for module discovery, followed by
module evaluation using the ISC dataset. In the parallel thread,
the ISC dataset was used for constructing modules and the GAIN
dataset for evaluation. In both threads, a series of significance tests
were performed, each of which aims to build null distributions for
different purposes and adjust specific biases. The modules that
passed the filtering criteria in both datasets were selected and
merged. Module genes were collected and considered as schizo-
phrenia candidate genes, whose association signals were further
examined in an independent GWAS dataset, the nonGAIN
dataset, as well as, by meta-analysis using three GWAS datasets
(ISC, GAIN, and nonGAIN).
More specifically, our algorithm for multiple GWAS datasets
includes the following steps.
Step 1. Candidate module search in one GWAS dataset. The
gene-wise P values from the GWAS results were converted to z-
Author Summary
The recent success of genome-wide association studies
(GWAS) has generated a wealth of genotyping data critical
to studies of genetic architectures of many complex
diseases. In contrast to traditional single marker analysis,
an integrative analysis of multiple genes and the assess-
ment of their joint effects have been particularly promis-
ing, especially upon the availability of many GWAS
datasets and other high-throughput datasets for numer-
ous complex diseases. In this study, we developed an
integrative analysis framework for multiple GWAS datasets
and demonstrated it in schizophrenia. We first constructed
a GWAS-weighted protein-protein interaction (PPI) net-
work and then applied a dense module search algorithm
to identify subnetworks with combinatory disease effects.
We applied combinatorial criteria for module selection
based on permutation tests to determine whether the
modules are significantly different from random gene sets
and whether the modules are associated with the disease
in investigation. Importantly, considering there are many
complex diseases with multiple GWAS datasets available,
we proposed a discovery-evaluation strategy to search for
modules with consistent combined effects from two or
more GWAS datasets. This approach can be applied to any
diseases or traits that have two or more GWAS datasets
available.
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scores and overlaid to the background human interactome (the
whole PPI network), with each node being weighted by the z-score
of the encoding genes. For each node in the network, DMS is
performed to generate a best module, i.e., with the largest module
score, Zm (see Materials and Methods). We performed this module
construction step for each GWAS dataset using the R package,
dmGWAS, which implements the original DMS algorithm [14],
and the default parameters were used.
Step 2. Module assessment. We provide three types of
significance tests to assess the candidate modules: (1) the
significance test based on module scores (P(Zm)); (2) the evaluation
of module scores in the context of various biases (PGL, PnSNPs, and
Ptopo); and (3) the permutation test by shuffling disease labels in the
GWAS datasets (Pemp). Detailed information can be found in the
Materials and Methods section.
Step 3. Module selection. In practice, several thousands of
modules are likely to be constructed, corresponding to the
thousands of genes used as seed; thus, further selection for top
modules is needed. In a single GWAS-weighted module search
process, we employed the following combinatorial criteria to select
modules: (1) P(Zm),0.05; (2) PGL,0.05, PnSNPs,0.05, and
Ptopo,0.05; and (3) Pemp,0.05. When there are two GWAS
datasets available for the same disease or trait, we propose to use
one dataset serving as discovery (discov) and the other as evaluation
(eval), and vice versa (Figure 1). This allows us to select the most
reliable modules with enriched association signals from more than
one study. For each module generated by the discovery dataset, we
also computed the corresponding P(Zm(eval)) using the same set of
genes (i.e., in the same module) with gene weights based on the
evaluation GWAS dataset, as well as Pemp(eval) by shuffling the case/
control labels in the evaluation GWAS dataset. Modules were
selected if they have P(Zm(eval)),0.05 and Pemp(eval),0.05.
Dense module search for schizophrenia
Using GAIN as the discovery dataset, we identified a total of
8,739 modules (Figure 2A). The module size ranged between 5
and 17, with a median value of 11 (Figure S2). A total of 935
modules passed the combinatorial criteria, i.e., (1) P(Zm),0.05; (2)
PGL,0.05, PnSNPs,0.05, and Ptopo,0.05; and (3) Pemp,0.05.
Among them, 71 modules were also significant in the ISC
evaluation dataset (P(Zm(eval)),0.05). Furthermore, 68 out these 71
modules passed the permutation test in the evaluation dataset
(Pemp(eval),0.05). They were denoted as the final list of modules.
Similarly, using ISC as the discovery dataset, we identified
8,899 modules (Figure 2B), with the module size ranging between
5 and 18 and a median value of 11 (Figure S2). A total of 259
Figure 1. Workflow of network-assisted strategy to identify candidate genes for schizophrenia.
doi:10.1371/journal.pcbi.1002587.g001
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modules passed the combinatorial criteria. However, only one
module was significant when adding the GAIN dataset for
evaluation, involving 11 genes. We then merged the two lists to
build a PPI subnetwork, which consisted of 205 module genes
(Figure S3).
Module genes as candidates for schizophrenia
A substantial proportion of the 205 module genes had
nominally significant P values (defined as P,0.05 without multiple
testing correction) in the corresponding GWAS dataset: 139
module genes (67.80%) had PGAIN,0.05, and 125 module genes
(60.98%) had PISC,0.05. The remaining module genes with non-
significant P values were recruited in the top modules due to their
physical interactions with the nominally significant genes in the
PPI network, as DMS aims to identify joint effects of a set of
schizophrenia genes in the context of the PPI network. In
summary, 97 of the 205 genes (47.32%) were nominally significant
in both the GAIN and ISC datasets, and 167 (81.46%) were
nominally significant in either dataset.
Further comparison of these genes with previous association
studies in the SZGene database [22] (as of January 26, 2011)
showed that 31 (15.12%) of the module genes had been studied for
association with schizophrenia. The SZGene database manually
curates the association results from previously published associa-
tion studies as well as recent GWAS findings. Among these 31
genes, 16 had at least one positive association study in previous
work. Eighteen of these 31 genes (58.06%) were nominally
significant (gene-wise P value,0.05) in both the GAIN and ISC
datasets, while 26 (83.87%) had nominal significance in either
dataset. These proportions were similar to those evaluated for the
whole 205 module genes above. In contrast, the corresponding
proportions of nominally significant genes in whole GWAS
datasets were much lower (16.43% genes with nominal signifi-
cance in both datasets and 55.77% in at least one dataset),
indicating that the identified module genes were closer to genes
known to be associated with schizophrenia.
Replication in an independent GWAS dataset
We further evaluated the 205 module genes in an independent
GWAS dataset, the nonGAIN dataset. First, we assessed whether
the module genes contain a proportion of significant genes than
randomly expected. This was done through weighted resampling
while controlling the potential biases of gene length and SNP
density in the nonGAIN dataset. Representing each module gene
by the smallest P value among the SNPs located in its gene region,
we denote the gene as significant if its nominal P value was less
than 0.05. The 205 module genes were pooled together and
denoted as one gene set, in which we found 76 genes were
observed to be nominally significant in the nonGAIN dataset. We
executed the weighted resampling process by 10,000 times, and
built a null distribution of the number of significant genes given
the number of module genes. This process was executed in the
same way as the second significance test in module assessment.
The details can be found in the Materials and Methods section, as
well as in previous study [23]. The empirical P for the module
gene set was 0.002 when adjusting gene length, and 0.003 when
adjusting SNP density, indicating that these genes are not expected
from random cases.
Second, we assessed the module genes in nonGAIN through
resampling of SNPs. The 205 module genes had a total of 15,548
SNPs in the nonGAIN dataset. In each resample, we randomly
selected the same number of SNPs (i.e., 15,548 SNPs) out of all the
SNPs genotyped in the nonGAIN dataset, and recorded the
number of significant SNPs, which were again defined as those
whose nominal P values,0.05. We repeated this process by 10,000
times and counted the number of resample processes having more
significant SNPs than that of the real case. This analysis resulted in
an empirical P value of 0.022, indicating that the SNPs harbored
in these module genes contained a higher proportion of nominally
significant SNPs than randomness.
Note that the nonGAIN dataset is independent of the GAIN
and ISC datasets we used to discover the module genes. Therefore,
these results provide an independent replication of our module
genes and showed that they are significantly enriched with
association signals to schizophrenia.
Meta-analysis
There were 15,252 SNPs in the genomic regions of the 205
module genes that were genotyped in all three GWAS datasets.
Using the inverse-variance weighted meta-analysis method and
heterogeneity test, we identified a total of 1032 SNPs having
nominal significance (Pmeta,0.05) after removing substantial
heterogeneity (Pheterogeneity,0.05).
To determine whether the module genes contain a proportion
of significant SNPs higher than expected by chance, we
randomly sampled SNP sets with the same number of SNPs
mapped to module genes (i.e., 15,252) and computed the
proportion of significant SNPs (defined as those with
Pmeta,0.05). Repeating the random process by 1000 times, we
computed the empirical P value by Pemp = f# random sample
sets with K§kg=ftotal # of random sample setsg, where K is
the number of significant SNPs with Pmeta,0.05 in a random set,
and k is the number in the real case, i.e., k= 1032. This random
process showed that the module genes contains a significantly
higher proportion of significant SNPs (Pemp,0.001), further
proving the enriched signal in the module genes.
Among the significant module SNPs by meta-analysis, 18
SNPs in 9 genes were shown to have Pmeta,1610
24 (Table 1).
The most significant module SNPs were located in the gene
HLA-DQA1, followed by MAD1L1 (Table 1, Figure 3). There are
two SNPs in HLA-DQA1 with Pmeta,1610
24: rs9272219
(Pmeta = 1.46610
26) and rs9272535 (Pmeta = 1.58610
25). Both
were in the top list reported in a previous combined analysis of
three GWAS datasets for schizophrenia [2,3,4], which included
all the GWAS datasets we used here plus the SGENE dataset
[4], to which we do not have access currently. The combined P
value in the previous work [4] was Pcomb = 6.9610
28 for
rs9272219 and Pcomb = 8.9610
28 for rs9272535. Both SNPs
are located in the MHC region chr6: 27,155,235–32,714,734, a
region that was reported to harbor a genome-wide significant
association signal for schizophrenia [2]. Another gene, MAD1L1,
has six SNPs with small Pmeta values (4.30610
26,6.0161025,
Table 1). MAD1L1 is a long gene (,417 kb) and has 70
overlapped SNPs examined in the meta-analysis. We further
examined whether these 6 SNPs are located in the same LD
block. Using the HapMap3 CEU data (http://www.hapmap.
org/, release R2), we found that these SNPs were located in 4
blocks, suggesting that they might represent independent
association signals.
Figure 2. Distribution of module scores (Zm) from two GWAS datasets. Each circle in the plot represents a module. The circles in red indicate
those selected modules (see text). X-axis: module scores from the discovery GWAS dataset. Y-axis: module scores from the evaluation GWAS dataset.
doi:10.1371/journal.pcbi.1002587.g002
Network-Based Investigation of SZ GWAS
PLoS Computational Biology | www.ploscompbiol.org 5 July 2012 | Volume 8 | Issue 7 | e1002587
Functional enrichment analysis
Table 2 summarizes the results of pathway enrichment analysis
of the 205 module genes by the Ingenuity Pathway Analysis (IPA).
Enrichment results of KEGG [15] pathways were shown in Table
S1. The enriched pathways included Wnt/b-catenin signaling,
CREB signaling in neurons, Calcium signaling, Ga12/13
signaling, and synaptic long term depression. Overall, the results
are consistent with the neuropathology and immune/inflamma-
tion hypotheses in schizophrenia [24,25], suggesting that our
DMS-based strategy is effective on detecting joint association
signals from multiple GWAS datasets.
Discussion
We proposed a novel strategy to prioritize candidate genes from
multiple GWAS datasets in the context of the human interactome
and applied it to schizophrenia. Integration of the PPI network
and implementation of our dense module search algorithm greatly
improved the coverage of gene annotations, introduced gene set
flexibility when searching for candidate genes, and allowed for
dynamic identification of putative genes. The bidirectional strategy
we proposed here made full use of the discovery and evaluation
datasets to avoid potentially incomplete discovery using either one
of them separately. The final subnetwork and candidate gene list
display the combined results of the two processes, namely GAIN
(discovery) R ISC (evaluation) and ISC (discovery) R GAIN
(evaluation); thus, they are comprehensive and cohesive in
revealing the signals from both datasets. At the molecular level,
the module genes we identified showed substantial overlap with
previous studies. We also identified novel genes that had not been
studied in schizophrenia, yet could be promising new candidates.
The procedure we proposed in this study implemented our
previously developed dense module search algorithm. One
important improvement is that we introduced P(Zm) for module
selection, instead of simply relying on the module score, Zm,
although the latter is straightforward and has been proved effective
in our previous work [14]. In this study, we adopted the Efron
et al. [26] method and computed P values based on Zm scores
through the estimation of empirical null distribution. Theoretical-
ly, Zm and the corresponding P(Zm) values are expected to have
identical rank, which has also been observed in real data
(Spearman correlation coefficient = 1). In contrast to applying a
straightforward cutoff value of Zm to perform module selection,
P(Zm) examines the overall distribution of all module scores and
has the advantage to provide a statistical evaluation. Thus, we
replaced Zm by P(Zm) for module selection in the current study.
Alternatively, using simulated genotyping and phenotype data to
estimate the proportions of modules that can capture the most
causal variants will help module selection. In such cases,
appropriate simulation data for the analyzed disease model is
important for both power estimation and module selection, and
will be considered in our future work.
One limitation of our method is that the dense module
searching process is sensitive to the background network. The
algorithm of DMS examines all the neighborhood nodes within
the distance of d and selects the best node in every step of module
expanding. Although this is an advantage to recruit the best
node(s) in each step, it also makes the DMS algorithm heavily rely
on the searching space defined by the background interactions.
Currently, our knowledge of human PPI network is far from
complete. To reduce the uncertainty of network data, we required
our working network only include interactions with experimental
Table 1. Results of meta-analysis using GAIN, nonGAIN, and ISC GWAS datasets (Pmeta,1610
24 and Pheterogeneity$0.05).
SNP ID Module Genes Chr. Position Allele Pmeta Beta s.e. PGAIN PnonGAIN PISC Pheterogeneity
rs9272219 HLA-DQA1 6 32710247 T/G 1.4661026 20.15 0.03 0.06 0.06 1.5861025 0.76
rs10244946 MAD1L1 7 1887594 A/G 4.3061026 20.16 0.03 1.8161024 0.18 2.3661023 0.27
rs3778994 MAD1L1 7 2142381 A/C 6.7961026 20.15 0.03 4.5461024 0.61 1.2061024 0.07
rs10275045 MAD1L1 7 1887352 T/C 9.7961026 20.13 0.03 1.4461024 0.20 3.6161023 0.16
rs4721190 MAD1L1 7 1921258 A/G 1.3961025 20.15 0.03 3.0761024 0.17 6.4261023 0.32
rs2056480 MAD1L1 7 1920827 A/G 1.4461025 20.12 0.03 4.1561025 0.31 5.6961023 0.07
rs9272535 HLA-DQA1 6 32714734 A/G 1.5861025 20.16 0.04 0.07 0.07 8.2761025 0.41
rs3132649 RPP21,TRIM39 6 30429036 A/G 1.6461025 20.20 0.05 0.01 0.46 6.4661027 0.00
rs10224497 MAD1L1 7 2116493 G/A 1.7561025 20.14 0.03 4.3261025 0.91 8.4661024 0.02
rs741326 CD207,CLEC4F 2 70912343 G/A 2.6561025 20.12 0.03 0.31 0.09 4.1461025 0.46
rs12646184 SMARCAD1 4 95402239 T/C 3.2161025 0.12 0.03 2.8561025 0.11 0.03 0.05
rs2071278 AGER, NOTCH4 6 32273422 G/A 3.2361025 20.16 0.04 0.10 0.98 2.7861026 0.06
rs2664871 SMARCAD1 4 95365304 T/C 4.6961025 0.12 0.03 3.8961025 0.12 0.04 0.05
rs172531 RERE 1 8418177 G/A 5.6261025 0.12 0.03 0.01 0.75 4.0361025 0.06
rs2087170 SMARCAD1 4 95381983 G/T 5.8361025 0.14 0.03 5.5961025 0.10 0.12 0.11
rs3757440 MAD1L1 7 2239462 G/A 6.0161025 20.14 0.04 6.4161024 0.56 2.3561023 0.14
rs301791 RERE 1 8390959 T/A 6.4561025 0.12 0.03 4.8861023 0.78 9.9061025 0.06
rs301801 RERE 1 8418532 C/T 6.6661025 0.12 0.03 0.01 0.73 4.5161025 0.06
rs302719 RERE 1 8412907 G/T 7.0161025 0.12 0.03 0.01 0.73 4.8461025 0.06
rs349171 PTPRG 3 62026751 T/C 9.3961025 20.16 0.04 0.50 0.08 9.5861025 0.35
rs8336 SMARCAD1 4 95430633 T/C 9.8161025 20.13 0.03 1.4361023 0.18 0.02 0.47
Rows were ordered by Pmeta.
doi:10.1371/journal.pcbi.1002587.t001
Network-Based Investigation of SZ GWAS
PLoS Computational Biology | www.ploscompbiol.org 6 July 2012 | Volume 8 | Issue 7 | e1002587
Network-Based Investigation of SZ GWAS
PLoS Computational Biology | www.ploscompbiol.org 7 July 2012 | Volume 8 | Issue 7 | e1002587
evidence while excluding interactions predicted by computational
algorithms. However, because our aim is to search for a
subnetwork that is significantly enriched with GWAS signals, the
background PPI network can be extended to any network that is
built under a rational biological hypothesis, e.g., co-expression
network, functional correlated network, or network based on co-
occurrence in literature. Using any of these potential datasets, the
strategy we proposed here can be easily extended while the aim is
always to search for a subnetwork that is significantly enriched
with association signals from GWAS data.
We performed meta-analysis using three GWAS datasets, two of
which have already been used for module construction. In the
latter case, the ISC and GAIN datasets were used at the gene and
module levels, while in the meta-analysis, the examination of the
three GWAS datasets was conducted at the SNP level, including
its mutation direction. The results of meta-analysis were intended
to provide a complementary view and further examination of
association signals of the module genes at the SNP level rather
than in any single GWAS dataset. Of note, an ideal way of
replication of the module genes is to test them in other datasets
that are completely independent of those having already been used
in the module construction step; however, there are only limited
number of independent GWAS datasets for schizophrenia at the
current stage. To partially accomplish this evaluation goal, we
examined the module genes in the nonGAIN dataset, an
independent dataset from those (ISC and GAIN) in module
selection. The evaluation results of the nonGAIN dataset thus
provide some replication evidence of the module genes.
There have been a few previous studies combining network data
with GWAS data. A representative method is DAPPLE, which
takes the association loci in GWAS datasets as input and tests
whether genes located in these loci are significantly connected via
PPI. The advantages of DAPPLE include that it does not require
the genotyping data of the original GWAS datasets, it provides a
comprehensive randomization test to address the high-degree
nodes, and it has an online tool for public use. Although DAPPLE
and the method we proposed here both use PPI network to
analyze GWAS data, they differ substantially in term of the
underlying hypothesis. DAPPLE tests whether the associated genes
are significantly connected compared to random networks while
our method searches for modules that are significantly associated
with the disease. Due to this main difference as the starting point,
the two methods differ in many aspects in the subsequent analyses,
such as the way to build the resultant network and the way to
evaluate the results. For example, DAPPLE only takes the
associated loci as input, which are typically defined by 561028
and all the other loci, including those with weak to moderate
association levels, would be discarded. This might be less efficient
in searching association modules, especially for diseases or traits
that do not have strong association signals from GWAS. For
example, for psychiatric diseases such as schizophrenia, association
signal of the markers in any single GWAS dataset failed to reach
the genome-wide significance level 561028. Specifically, if we use
DAPPLE to analyze any of the three GWAS datasets used in this
study, we would not have any associated loci based on the
significance level 561028. In contrast, DMS considers all the
genes genotyped in the GWAS as input (seeds) in the network, and
searches for the final modules in a weight-guided fashion. Here,
the weight is from GWAS P values. Subsequently, many
moderately associated genes (e.g., those with P values between
0.05,561028) might have chance to be included in the final
modules for an examination of their joint effects. In practice,
depending on the purposes of each study and data availability,
investigators may choose appropriate methods for their specific
testing.
The merged subnetwork (Figure S3) included a number of well-
studied candidate genes for schizophrenia, such as DISC1, DLG2,
DLG3, DRD5, GNA12, GNA13, and GNAI1. Many genes have been
Table 2. Enriched pathways for module genes by Ingenuity Pathway Analysis.
Ingenuity Canonical Pathways -log(PBH) Molecules
Huntington’s Disease Signaling 7.17 GRIN2B, HDAC2, GRB2, CREBBP, HDAC1, GNB2L1, DNM3, ITPR1, POLR2B, SIN3A,
EP300, JUN, IGF1, CACNA1B, PRKCE, PIK3CB, PRKCH, EGFR
Wnt/b-catenin Signaling 6.52 GJA1, TGFBR3, HDAC1, CREBBP, SOX13, ACVR1B, EP300, MYC, CDH2, CDH1, JUN,
CSNK2A1, CTNNB1, ACVR2A, SOX5
Androgen Signaling 4.97 JUN, AR, GNA12, GNB2L1, CREBBP, GNAI1, PRKCE, PRKCH, POLR2B, GNA13, EP300
CREB Signaling in Neurons 4.86 GRIN2B, GRB2, GNA12, GNB2L1, CREBBP, GNAI1, POLR2B, ITPR1, EP300, PRKCE,
PIK3CB, PRKCH, GNA13
Prolactin Signaling 4.82 MYC, FYN, JUN, GRB2, CREBBP, PRKCE, PIK3CB, PRKCH, EP300
TGF-b Signaling 4.40 JUN, GRB2, HDAC1, CREBBP, SMAD7, SMAD5, ACVR2A, ACVR1B, EP300
Calcium Signaling 4.31 GRIN2B, TNNT1, TRPC1, HDAC2, RYR3, RYR2, HDAC1, CREBBP, MYH9, ITPR1, ACTA1,
EP300
Ga12/13 Signaling 4.12 CDH2, CDH1, JUN, F2R, GNA12, IKBKE, PIK3CB, GNA13, CDH16, CTNNB1
Synaptic Long Term Depression 3.97 PRKG1, IGF1, GNA12, RYR3, RYR2, GNAI1, PRKCE, PRKCH, GNA13, ITPR1
Dopamine-DARPP32 Feedback in cAMP Signaling 3.80 KCNJ12, PPP1CC, GRIN2B, PRKG1, CREBBP, GNAI1, CACNA1C, PRKCE, DRD5, PRKCH,
ITPR1
P values adjusted by Benjamini & Hochberg (BH) method [33].
doi:10.1371/journal.pcbi.1002587.t002
Figure 3. Meta-analysis results of the two most significant genes. Figures were generated using the LocusZoom online tool. X-axis is the
genome coordinate. Y-axis is the -logPmeta values. Each point represents a SNP. The color of points is according to their level of linkage disequilibrium
(LD) with the index SNPs. In this case, the index SNP is the most significant one in each panel. The LD measure is r2 based on the HapMap CEU
population (release 22).
doi:10.1371/journal.pcbi.1002587.g003
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studied in previous association studies [2,3]. Interestingly, GRB2
was present in the merged network. We identified GRB2 as a
candidate gene for schizophrenia in our previous study through a
network-assisted strategy [24] and then validated it in the Irish
Case Control Study of Schizophrenia (ICCSS) sample [27]. Here,
using an independent strategy and datasets, we again identified
this gene, further supporting GRB2 as a candidate gene for
schizophrenia. The canonical pathways enriched in the module
genes also confirmed the involvement of neuro-related genes and
pathways in schizophrenia.
In summary, we have performed a comprehensive network-
based analysis using our DMS-based approach augmented with
IPA software to facilitate interpretation. The outcome of this
analysis not only supports previously reported associations with
schizophrenia, but also implicates functional components such as
the Calcium signaling, Ga12/13 signaling, and the synaptic long
term depression pathways in schizophrenia risk. Future work to
estimate the power of this network-based strategy through
simulation and validation in independent samples will enhance
the applications of this method in other diseases or traits.
Materials and Methods
GWAS datasets
The Genetic Association Information Network (GAIN) dataset
for schizophrenia was genotyped using the Affymetrix Genome-
Wide Human SNP 6.0 array, and our access to it was approved by
the GAIN Data Access Committee (DAC request #4532-2)
through the NCBI dbGaP. We used the samples of European
ancestry. Quality control (QC) was executed as follows. For
individuals, we excluded those with a high missing genotype rate
(.5%), extreme heterozygosity rate (63 s.d. from the mean value
of the distribution), or problematic gender assignment. We used
PLINK [28] to compute the identify-by-state (IBS) matrix to
pinpoint duplicate or cryptic relationships between individuals,
and we retained the sample with the highest call rate for each pair
of samples with an identity-by-descent (IBD).0.185. Principle
component analysis (PCA) was performed using the smartpca
program in EIGENSTRAT [29] to detect population structure
and to allow removal of outlier individuals. Eight significant PCs
with the Tracy Widom test P value,0.05 were then used as
covariates for logistic regression (additive model). For genotyped
SNPs, we removed those with a missing genotype rate.5%, minor
allele frequency (MAF),0.05, or departing from Hardy-Weinberg
equilibrium (P,161026). The final analytic dataset included
1,158 schizophrenia cases, 1,377 controls, and a total of 654,271
SNPs with a genomic inflation factor l=1.04.
The International Schizophrenia Consortium (ISC) samples
were collected from eight study sites in Europe and the US [2].
The samples were genotyped using Affymetrix Genome-Wide
Human SNP 5.0 and 6.0 arrays, and this data was initially
analyzed by ISC [2]. A total of 3,322 patients with schizophrenia,
3,587 normal controls of European ancestry, and 739,995 SNPs
were included in our analysis. To account for potential population
structure caused by collection sites, we used the Cochran-Mantel-
Haenszel test for a single marker association test, following the
original report [2].
The Molecular Genetics of Schizophrenia (MGS) - nonGAIN
dataset (denoted as ‘‘nonGAIN’’ hereafter) was genotyped in the
same laboratory as GAIN, but in different phases. Access to this
dataset was approved by dbGaP (DAC request #4533-3). Similar
QC and PCA as described for GAIN were performed. This
process retained 1,068 cases and 1,268 controls, all of which are of
European ancestry, and 623,059 SNPs for subsequent analysis.
Fifteen significant PCs with the Tracy-Widom test P value,0.05
were used as covariates for logistic regression (additive model)
using PLINK, with l=1.04.
We mapped SNPs to human protein-coding genes downloaded
from NCBI ftp site (Build 36). A SNP was assigned to a gene if it
was located within or 20 kb upstream/downstream of the gene
[30]. Each gene was assigned a gene-wise P value using the P value
of the gene’s most significant SNP. A total of 19,739 genes were
successfully mapped in the GAIN dataset and 19,910 in the ISC
dataset.
Human protein-protein interaction (PPI) network
A comprehensive human PPI network was downloaded from
the Protein Interaction Network Analysis (PINA) platform [31]
(March 4, 2010), which collects and annotates data from six public
PPI databases (MINT, IntAct, DIP, BioGRID, HPRD, and
MIPS/MPact). To ensure the reliability of the network, we only
kept those interactions having experimental evidence and both
interactors are human proteins. Our working network included a
total of 10,377 nodes (genes) and 50,109 interactions. Only
common genes that were represented in both GWAS and PPI
datasets were retained for subsequent analysis.
Dense module search analysis
We applied our recently developed dense module search (DMS)
algorithm [14] with substantial improvement to these schizophre-
nia GWAS datasets. Details of the DMS algorithm are provided in
reference [14]. Briefly, DMS works with a node-weighted PPI
network and searches for a best module for each node in a score-
guided fashion. A quantitative description of the network includes
each node weighted by z~W{1(1{P), where W{1 is the inverse
normal cumulative density function and P is the P value
representing the association signal in the gene region (which we
called the gene-wise P value) from the GWAS dataset. Each
module is scored by Zm~
P
zi=
ﬃﬃﬃ
k
p
, where k is the number of
nodes (genes) in the module.
Given a single GWAS dataset, we first overlay gene-wise P
values to the PPI network to generate a GWAS P value-weighted
working network. We then took each of the nodes in the network
as a seed gene, and searched for a best scored module for it. In
each case, starting with the seed ‘module’ formed by the seed
node, the DMS algorithm searches for the node with the highest
score in the neighborhood within a distance d (d=2) to the seed
module. Then, the module is expanded by adding the highest-
scored node if Zm+1.Zm6(1+r), where Zm+1 is the new module
score after adding the node, Zm is the original module score and r is
a pre-defined rate. We set r to be 0.1 in this study. This module
expansion process iterates until none of the neighborhood nodes
can satisfy the function Zm+1.Zm6(1+r). Because this module
construction process was conducted taking each node in the
network as the seed gene, several thousands of modules are
expected corresponding to the thousands of nodes.
Module assessment
We provided three procedures to assess the significance of the
identified modules, each of which aims to build null distributions
for different hypotheses.
First, to perform significance test of the identified modules, we
calculated P values based on module scores (Zm) for each module
by empirically estimating the null distribution [26]. According to
Efron et al. (2010), the null distribution is a normal distribution
with mean d and standard deviation s, both of which can be
empirically estimated using the R package locfdr. Specifically,
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module scores were first median-centered by subtracting the
median value of Zm from each of them, followed by estimation of
the parameters of d and s for the empirical null distribution using
locfdr. The standardized module scores (ZS) were then calculated
and converted to P values, P(Zm) = 1-W(ZS), where W is the normal
cumulative density function.
Second, to determine whether the module score is higher than
expected by chance, a standard way is to randomly select the same
number of genes in a module, i.e., resample genes in the network
regardless of the interactions, and compare the module score in
the random gene set with the score in the real case. Specifically to
alleviate the biases in GWAS data (e.g., gene length or SNP
density) or the network data (e.g., high-degree nodes), we
incorporated weighted resampling which intentionally matches
the pattern of biases in each resample to resemble the real case.
The gene length bias and the SNP density bias are commonly
noticed in GWAS datasets, especially when using the most
significant SNP to represent genes [30]. This is because when
mapping SNPs to genes, longer genes tend to have more SNPs and
in turn have higher chance to be significant. These two types of
biases are closely correlated but differ in cases due to different
genotyping platforms. For both biases, we first estimate a weight
for each gene based on the specific character to be adjusted, and
then performed weighted resampling to ensure each of the
resample has the similar pattern in term of the adjusted character.
This weighted resampling procedure ensures that genes could be
selected in a similar pattern of gene length or SNP density as in the
real GWAS data. Therefore, the empirical P values for each
module built on the bias-matched permutation data could be
adjusted by gene length (PGL) or the number of SNPs per gene
(PnSNPs). A detailed description of this function can be found in
previous work [23].
Another type of bias was that, in the PPI network, nodes with
many interactors (high degree) are more likely to be recruited in
module expansion steps. We thus categorized all the nodes in the
working PPI network into four categories by their degree values
(degree range 0–22, 22–24, 24–26, and .26) (Figure S1). For each
module, a topologically matched random module was generated
by randomly sampling the same number of nodes in each of the
four node bins. An empirical P value is computed by Ptopo~
PrfZm(p)§Zmg~#of resamplesfZm(p)§Zmgz1
total #of resamplesz1
, where
Zm(p) is the score of the random module for the p
th resample,
and Zm is the observed module score.
Third, to assess the disease association of the modules, we
performed permutation test by shuffling case/control labels in the
GWAS datasets. We generated 1,000 permutation datasets using
the genotyping data, and computed module scores in each
permutation dataset in the same way as for the real case. An
empirical P value for each module was computed according to
Pemp~PrfZm(permutation)§Zmg, where Zm(permutation) is the
module score in the permutation data.
A combinatorial set of criteria was defined to select modules: (1)
P(Zm),0.05; (2) PGL,0.05, PnSNPs,0.05, and Ptopo,0.05; and (3)
Pemp,0.05. This set of combinatorial criteria is applied whenever
one GWAS dataset is used to identify, assess and select modules.
When there is an additional GWAS dataset available for
evaluation, we included two additional criteria: (1) P(Zm(eval)),0.05
and/or (2) Pemp(eval),0.05.
Meta-analysis
Meta-analysis of module genes was conducted using three major
GWAS datasets: ISC, GAIN, and nonGAIN. A quality control
step was performed before the meta-analysis to detect whether
there is duplication or cryptic relatedness among the samples in
the three GWAS datasets. Pairwise IBS was computed using an
unrelated list of markers (generated through the option ‘‘–indep-
pairwise 50 5 0.2’’ in PLINK [32]). No pair was observed with an
IBD.0.185, a cutoff value that is halfway between the expected
IBD for third- and second-degree relatives. We performed inverse-
variance weighted meta-analysis based on the fixed-effects model
using the tool meta (http://www.stats.ox.ac.uk/,jsliu/meta.html).
This method combines study-specific beta values under the fixed-
effects model using the inverse of the corresponding standard
errors as weights. Between-study heterogeneity was tested based
on I2 and Q statistics. SNPs with evidence of heterogeneity were
removed.
The three GWAS datasets were genotyped on the same
platform; thus, we performed meta-analysis directly on the
genotyped SNPs without imputation. Genomic control within
each study was conducted in the meta-analysis using the lambda
value to adjust the study-specific standard error (SE).
Functional enrichment tests
We performed pathway enrichment analysis by the IPA system
(http://www.ingenuity.com) and also using canonical pathways
from the KEGG database [9] by the hypergeometric test. The
KEGG pathway annotations were downloaded in March 2011,
containing 201 pathways with size $10 and #250. For each gene
set collection, the results by the hypergeometric test were adjusted
by the Bonferroni method for multiple testing correction. To
further assess the significance of the identified gene sets, we
performed empirical assessment of the significance by resampling
1000 times from the network genes, with each resample containing
a random set of 205 genes. For a gene set S, we recorded the
number of resamples in which the gene set was significant and
computed an empirical P value by Pemp~#resamples
fS is significantg=total#resamples.
Supporting Information
Figure S1 Degree distribution of GAIN GWAS-weighted (top)
and ISC GWAS-weighted (bottom) networks. Each node in the
network was assigned to a degree bin based on its -log2(degree)
value.
(PDF)
Figure S2 Module size distribution of GAIN GWAS-weighted
(top) and ISC GWAS-weighted (bottom) networks.
(PDF)
Figure S3 Protein-protein interaction network consisting of
module genes for schizophrenia.
(PDF)
Table S1 Functional enrichment results using KEGG pathways
for module genes.
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